Suppr超能文献

癌症生存率:测量方法、用途及解读概述

Cancer survival: an overview of measures, uses, and interpretation.

作者信息

Mariotto Angela B, Noone Anne-Michelle, Howlader Nadia, Cho Hyunsoon, Keel Gretchen E, Garshell Jessica, Woloshin Steven, Schwartz Lisa M

机构信息

Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD (AM, AN, NH, HC); Division of Cancer Registration and Surveillance, National Cancer Center, Goyang-si Gyeonggi-do, Korea (HC); Information Management Services, Inc., Calverton MD (GEK, JG); Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH, Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center, Lebanon, NH, Geisel School of Medicine at Dartmouth, Hanover, NH, Department of Veterans Affairs Medical Center, Veterans Affairs Outcomes Group, White River Junction, VT (SW, LMS).

出版信息

J Natl Cancer Inst Monogr. 2014 Nov;2014(49):145-86. doi: 10.1093/jncimonographs/lgu024.

Abstract

Survival statistics are of great interest to patients, clinicians, researchers, and policy makers. Although seemingly simple, survival can be confusing: there are many different survival measures with a plethora of names and statistical methods developed to answer different questions. This paper aims to describe and disseminate different survival measures and their interpretation in less technical language. In addition, we introduce templates to summarize cancer survival statistic organized by their specific purpose: research and policy versus prognosis and clinical decision making.

摘要

生存统计数据对于患者、临床医生、研究人员和政策制定者来说都极具意义。尽管生存情况看似简单,但实则可能令人困惑:存在许多不同的生存指标,有着大量的名称以及为回答不同问题而开发的统计方法。本文旨在用较为通俗易懂的语言描述并传播不同的生存指标及其解读。此外,我们还引入了模板,以便根据其特定目的总结癌症生存统计数据:研究与政策目的以及预后与临床决策目的。

相似文献

1
Cancer survival: an overview of measures, uses, and interpretation.
J Natl Cancer Inst Monogr. 2014 Nov;2014(49):145-86. doi: 10.1093/jncimonographs/lgu024.
3
Do evidence summaries increase health policy-makers' use of evidence from systematic reviews? A systematic review.
Campbell Syst Rev. 2018 Sep 10;14(1):1-52. doi: 10.4073/csr.2018.8. eCollection 2018.
4
Challenges in the estimation of Net SURvival: The CENSUR working survival group.
Rev Epidemiol Sante Publique. 2016 Oct;64(5):367-371. doi: 10.1016/j.respe.2016.05.005. Epub 2016 Oct 25.
5
The future of Cochrane Neonatal.
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
6
7
Immortal person-time in studies of cancer outcomes.
J Clin Oncol. 2009 Aug 10;27(23):e55-6. doi: 10.1200/JCO.2009.24.1877. Epub 2009 Jul 13.
9
Life tables for world-wide comparison of relative survival for cancer (CONCORD study).
Tumori. 2008 Sep-Oct;94(5):658-68. doi: 10.1177/030089160809400503.
10

引用本文的文献

1
2
Renal cancer survival in clear cell renal cancer compared to other types of tumor histology: A population-based cohort study.
PLoS One. 2025 Jul 31;20(7):e0329000. doi: 10.1371/journal.pone.0329000. eCollection 2025.
3
Prognosis of NETs: Has There Been Improvement over the Last 30 Years?
Neuroendocrinology. 2025 May 30:1-13. doi: 10.1159/000546613.
5
Breast cancer in patients under 40 years: an 11-year retrospective cohort analysis.
Arch Gynecol Obstet. 2025 May 15. doi: 10.1007/s00404-025-08031-5.
9
Survival analysis for cardiothoracic surgeons: part 6-interpreting time-to-event data.
Indian J Thorac Cardiovasc Surg. 2025 May;41(5):629-644. doi: 10.1007/s12055-025-01911-0. Epub 2025 Mar 8.

本文引用的文献

2
The Surveillance, Epidemiology, and End Results Cancer Survival Calculator SEER*CSC: validation in a managed care setting.
J Natl Cancer Inst Monogr. 2014 Nov;2014(49):265-74. doi: 10.1093/jncimonographs/lgu021.
3
Providing clinicians and patients with actual prognosis: cancer in the context of competing causes of death.
J Natl Cancer Inst Monogr. 2014 Nov;2014(49):255-64. doi: 10.1093/jncimonographs/lgu022.
4
Current estimates of the cure fraction: a feasibility study of statistical cure for breast and colorectal cancer.
J Natl Cancer Inst Monogr. 2014 Nov;2014(49):244-54. doi: 10.1093/jncimonographs/lgu015.
6
Adolescent and young adult cancer survival.
J Natl Cancer Inst Monogr. 2014 Nov;2014(49):228-35. doi: 10.1093/jncimonographs/lgu019.
7
The impact of state-specific life tables on relative survival.
J Natl Cancer Inst Monogr. 2014 Nov;2014(49):218-27. doi: 10.1093/jncimonographs/lgu017.
8
The impact of follow-up type and missed deaths on population-based cancer survival studies for Hispanics and Asians.
J Natl Cancer Inst Monogr. 2014 Nov;2014(49):210-7. doi: 10.1093/jncimonographs/lgu016.
10
When do changes in cancer survival mean progress? The insight from population incidence and mortality.
J Natl Cancer Inst Monogr. 2014 Nov;2014(49):187-97. doi: 10.1093/jncimonographs/lgu014.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验